Coenzyme Q(10): a novel therapeutic approach for Fibromyalgia? case series with 5 patients. – Cost Effective Supplements

Coenzyme Q(10): a novel therapeutic approach for Fibromyalgia? case series with 5 patients.

Quick navigation

Link
Conclusion
Supplements
Functions
Systems

Link to full study

http://www.ncbi.nlm.nih.gov/pubmed/21496502

Conclusion of this study

Patients were evaluated clinically with Visual Analogical Scale of pain (VAS), and Fibromyalgia Impact Questionnaire (FIQ). Patients with CoQ(10) deficiency showed a statistically significant reduction on symptoms after CoQ(10) treatment during 9 months (300 mg/day). Determination of deficiency and consequent supplementation in FM may result in clinical improvement. Further analysis involving more scientifically rigorous methodology will be required to confirm this observation.